Skip to main content
Clinical Trials/ACTRN12610000930088
ACTRN12610000930088
Completed
Phase 4

In patients undergoing surgeries pertaining to the muscular skeletal system, are the combined use of the target-controlled infusion of remifentanil with desflurane during the maintenance phase of general anesthesia lowering the end-tidal concentration of desflurane compared with desflurane only group?

Samsung Changwon Hospital0 sites90 target enrollmentNovember 2, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
end-tidal concentration of desflurane in patients undergoing surgeries pertaining skeletal muscular system
Sponsor
Samsung Changwon Hospital
Enrollment
90
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Samsung Changwon Hospital

Eligibility Criteria

Inclusion Criteria

  • the patients undergoing surgeries pertaing muscular skeletal system, without the change of body positioning and expected to have a blood loss rate lower than 200ml

Exclusion Criteria

  • body weight lower than 45 kg or greater than 100 kg, history of severe underlying cardiovascular, pulmonary, renal or hepatic disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials